8. ハンチントン病 Huntington disease Clinical trials / Disease details

臨床試験数 : 242 / 薬物数 : 205 - (DrugBank : 62) / 標的遺伝子数 : 85 - 標的パスウェイ数 : 159

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03980938 (ClinicalTrials.gov)	July 8, 2019	7/6/2019	Within Subject Crossover Study of Cognitive Effects of Neflamapimodin Early-Stage Huntington Disease ...	A Double-Blind, Placebo-Controlled Two-Period 10-Week Treatment Within-Subject Crossover Study Of Co ...	Huntington Disease	Drug: neflamapimod;Other: Placebo	EIP Pharma Inc	Voisin Consulting, Inc.	Terminated	30 Years	70 Years	All	15	Phase 2	United Kingdom
2	EUCTR2018-004840-51-GB (EUCTR)	26/06/2019	22/03/2019	Study of Neflamapimod in Early-Stage Huntington Disease (HD)	A Double-Blind, Placebo-Controlled Two-Period 10-Week Treatment Within-Subject Crossover Study Of Co ...	Early-Stage Huntington Disease MedDRA version: 20.0;Level: PT;Classification code 10070668;Term: Hun ...	Product Name: Neflamapimod Product Code: VX-745 INN or Proposed INN: Neflamapimod Other descriptive nam ...	EIP Pharma, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	16	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...	United Kingdom

First Previous1Next Last